Analytical Development Scientist I-II jobs in United States
cer-icon
Apply on Employer Site
company-logo

ALK · 16 hours ago

Analytical Development Scientist I-II

positionPost Falls, Post Falls, ID, US
timeFull-time
remoteOnsite
senioritySenior Level
money$70K/yr - $85K/yr
date5+ years exp

ALK Abello' Source Materials, Inc. is a leading manufacturer of quality allergenic biological source materials. The Analytical Development Scientist is responsible for providing analytical method development support for new and existing products, participating in the development and validation of analytical procedures, and managing in-house references and reagent inventories.

Health Care
check
Culture & Values

Responsibilities

Providing analytical method development support for new and existing products in support of EP/EMA initiatives
Participating in the development, qualification, and validation of analytical procedures, including writing protocols and reports
Performing and evaluating existing immunological, separation and chromatographic methods
Managing in-house references and reagent inventories
Instrument maintenance
Accurately maintaining documentation

Qualification

Analytical method developmentICH guidelinesPharmaceutical industry experienceQuality SystemsRegulatory requirementsProblem solvingCommunication skillsProject management

Required

Bachelor's degree in biological sciences, biochemistry, chemistry or related field
Minimum 5+ years of relevant experience or equivalent combination of education and relevant experience
Hands on experience and understanding of common analytical and scientific methods
Ability to analyze data and draw conclusions based on that data
Ability to work with Quality Systems and regulatory requirements such as: CFRs, GMP, FDA, OSHA, and European Authority
Strong analytical and problem solving skills
Customer/team focus
Good communication skills
Ability to prioritize and manage multiple projects

Preferred

Relevant pharmaceutical industry experience
Experience developing and validating analytical methods according to ICH guidelines

Company

ALK

twittertwitter
company-logo
We are the pioneers of allergy solutions. Allergy is the most common chronic disease globally and it has profound impact on people’s lives.
dateFounded in 1923
location
Hørsholm, Hovedstaden, DNK
people-size1001-5000 employees
web-link
http://www.alk.net

Funding

Current Stage
Public Company
Total Funding
unknown
2000-03-10IPO

Leadership Team

leader-logo
Carsten Hellmann
President & CEO
linkedin
leader-logo
Peter Andersen
Senior Vice President of Global Research and Drug Discovery
linkedin

Recent News

venturelab.swiss
Allegria Therapeutics secures USD 5.1 million Seed extension financing
2025-12-13
startupticker.ch
USD 5 million to accelerate ALLEGRIA’s anti-allergy portfolio
2025-12-13
Venture Capital
Swiss Biotech Allegria Therapeutics Secures $5.1M Seed Extension Financing
2025-12-12
Company data provided by crunchbase